Integra LifeSciences Holdings Corporation Partners With TomoTherapy to Deliver Image-Guided Stereotactic Radiosurgery

PLAINSBORO, N.J., Oct. 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc., has entered into a strategic alliance with TomoTherapy Incorporated (Nasdaq:TTPY). The companies will develop and supply the InterFix(TM) radiosurgery kit, a collection of stereotactic radiosurgery components for the TomoTherapy(R) Hi-Art(R) system. The Hi-Art(R) treatment system is an advanced radiation delivery system for the treatment of cancer and combines integrated computed tomography (CT) imaging with sophisticated conformal control of target volume irradiation.

MORE ON THIS TOPIC